SmartRent, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SmartRent, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $152.33M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $174.89M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $236.84M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $167.82M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $110.64M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $52.53M | Mar 8, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $152.33M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $174.89M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $236.84M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $167.82M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $110.64M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $52.53M | Mar 8, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($60.56M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($33.64M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | ($34.59M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | ($96.32M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | ($71.96M) | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | ($37.11M) | Mar 8, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($63.98M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($41.77M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | ($43.16M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | ($104.25M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | ($71.65M) | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | ($35.72M) | Mar 8, 2023 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.22M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $29.37M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $28.81M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $29.42M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $21.57M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $9.41M | Mar 8, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($21.58M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($32.91M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $5.98M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | ($77.83M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | ($70.38M) | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | ($28.49M) | Mar 8, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.55M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $1.77M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $147.0K | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $1.11M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $1.47M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $298.0K | Mar 8, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $320.93M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $420.18M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $509.76M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $560.85M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $579.68M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $103.85M | Mar 25, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.79M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $130.74M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | $167.31M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | $196.65M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $130.18M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $70.67M | Mar 25, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $232.14M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $289.44M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $342.45M | Mar 4, 2026 |
| FY2025 | Dec 31, 2022 | $364.20M | Mar 4, 2026 |
| FY2024 | Dec 31, 2021 | $449.50M | Mar 5, 2025 |
| FY2023 | Dec 31, 2020 | ($78.25M) | Mar 5, 2024 |
| FY2022 | Dec 31, 2019 | ($44.43M) | Mar 8, 2023 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $92.34M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $117.27M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $117.27M | Mar 4, 2026 |
| FY2023 | Dec 31, 2022 | $117.27M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | $12.67M | Mar 8, 2023 |
| FY2022 | Aug 24, 2021 | $0 | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | $4.16M | Mar 25, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($413.29M) | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | ($347.85M) | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | ($285.51M) | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | ($250.93M) | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | ($154.60M) | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | ($82.64M) | Mar 25, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $104.55M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | $142.48M | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | $215.21M | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | $210.41M | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | $430.84M | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | $38.62M | Mar 8, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | (4) | Mar 8, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 4, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 4, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 5, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 5, 2024 |
| FY2022 | Dec 31, 2020 | (4) | Mar 8, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 189.68M | Mar 4, 2026 |
| FY2025 | Dec 31, 2024 | 192.05M | Mar 4, 2026 |
| FY2024 | Dec 31, 2023 | 203.33M | Mar 5, 2025 |
| FY2023 | Dec 31, 2022 | 198.53M | Mar 5, 2024 |
| FY2022 | Dec 31, 2021 | 193.86M | Mar 8, 2023 |
| FY2021 | Dec 31, 2020 | 10,376 | Mar 25, 2022 |